Bayer Aleve Gelcaps Backed With $28 Mil. In Ad/Promo Spend
This article was originally published in The Tan Sheet
Executive Summary
Bayer Consumer Care Division is supporting the introduction of Aleve Gelcaps with $28 mil. in advertising, free-standing inserts and sampling running through 1999. Appearing on store shelves beginning the week of Jan. 4, the gelcaps contain the same naproxen sodium 220 mg as Aleve tablets and caplets.
You may also be interested in...
Bayer Aleve Line Expanding With Cold & Sinus Offering
Bayer Consumer Care will be extending its Aleve line of pain relievers into the cough/cold category following FDA's approval of Aleve Cold & Sinus Nov. 29.
Bayer Aleve Line Expanding With Cold & Sinus Offering
Bayer Consumer Care will be extending its Aleve line of pain relievers into the cough/cold category following FDA's approval of Aleve Cold & Sinus Nov. 29.
Bayer Aleve Line Expanding With Cold & Sinus Offering
Bayer Consumer Care will be extending its Aleve line of pain relievers into the cough/cold category following FDA's approval of Aleve Cold & Sinus Nov. 29.